Skip to content

Clinical trials

Completed Genetic Diseases, Inborn trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Status: Completed Country / region: Israel Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20071
20111
20131
20173
20183
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S3
BioMarin Pharmaceutical2
Alnylam Pharmaceuticals1
Carmel Medical Center1
Genzyme, a Sanofi Company1
Novartis Pharmaceuticals1
PTC Therapeutics1
Pfizer1
Quince Therapeutics S.p.A.1
Spark Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn13
Blood Coagulation Disorders4
Blood Coagulation Disorders, Inherited4
Coagulation Protein Disorders4
Hematologic Diseases4
Hemophilia A4
Hemorrhagic Disorders4
Genetic Diseases, X-Linked3
Hemostatic Disorders2
Hyperoxaluria, Primary2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.